-
1
-
-
0034852909
-
Salivary anti-C andida activity and saliva composition in a HIV-infected cohort
-
Lin AL, Johnson DA, Patterson TF, Wu Y, Lu D L, Shi Q, et al. Salivary anti-C andida activity and saliva composition in a HIV-infected cohort. Oral Microbiol Immunol. 2001; 16: 270-278.
-
(2001)
Oral Microbiol Immunol
, vol.16
, pp. 270-278
-
-
Lin, A.L.1
Johnson, D.A.2
Patterson, T.F.3
Wu, Y.4
Lu, D.L.5
Shi, Q.6
-
2
-
-
13844319170
-
Isolat ion characterization of Candida spp
-
in Jordanian cancer patients: Prevalence, pathogenic determinants, and antifungal sensitivity
-
Al-Abeid HM, Abu-Elteen KH, Elkarmi AZ, Hamad MA. Isolat ion characterization of Candida spp. in Jordanian cancer patients: Prevalence, pathogenic determinants, and antifungal sensitivity. Jpn J Infect Dis. 2004; 57: 279-284.
-
(2004)
Jpn J Infect Dis
, vol.57
, pp. 279-284
-
-
Al-Abeid, H.M.1
Abu-Elteen, K.H.2
Elkarmi, A.Z.3
Hamad, M.A.4
-
3
-
-
4143136899
-
Candidiasis
-
In: Dolin R, Masur H, Saag M, eds. 2nd ed. Philadelphia, PA: Churchill-Livingstone
-
Fichtenbaum CJ. Candidiasis. In: Dolin R, Masur H, Saag M, eds. AIDS T herapy. 2nd ed. Philadelphia, PA: Churchill-Livingstone; 2003: 531-542.
-
(2003)
AIDS T herapy
, pp. 531-542
-
-
Fichtenbaum, C.J.1
-
4
-
-
0042164140
-
Fungal infec tions associated with HIV infection
-
Samaranayake LP, Fidel PL, Naglik JR, Sweet SP, Teanpaisan R, Coogan MM, et al. Fungal infec tions associated with HIV infection. Oral Dis. 2002; 8: 151-160.
-
(2002)
Oral Dis
, vol.8
, pp. 151-160
-
-
Samaranayake, L.P.1
Fidel, P.L.2
Naglik, J.R.3
Sweet, S.P.4
Teanpaisan, R.5
Coogan, M.M.6
-
5
-
-
0031980345
-
Rapid identification of Candida albicans and other human pathogenic yeast by using short oligonucleotides in a PCR
-
Mannarelli BM, Kurtzman CP. Rapid identification of Candida albicans and other human pathogenic yeast by using short oligonucleotides in a PCR. J Clin Microbiol. 1998; 36: 1634-1641.
-
(1998)
J Clin Microbiol
, vol.36
, pp. 1634-1641
-
-
Mannarelli, B.M.1
Kurtzman, C.P.2
-
6
-
-
0037667327
-
-
National Committee for Clinical Laboratory Standards. Approved standard. 2nd ed. NCCLS Document M27-A2. Wayne, PA: National Committee for Clinical Laboratory Standards
-
National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard. 2nd ed. NCCLS Document M27-A2. Wayne, PA: National Committee for Clinical Laboratory Standards, 2002.
-
(2002)
Reference method for broth dilution antifungal susceptibility testing of yeasts
-
-
-
7
-
-
0035217138
-
Antifungal sus ceptibility testing: New technology and clinical application
-
Pfaller MA, Yu WL. Antifungal sus ceptibility testing: new technology and clinical application. Infect Dis Clin North Am. 2001; 15: 1227-1261.
-
(2001)
Infect Dis Clin North Am
, vol.15
, pp. 1227-1261
-
-
Pfaller, M.A.1
Yu, W.L.2
-
8
-
-
0036891282
-
Antifungal susceptibility of South African oral yeast iso lates from HIV/AIDS patients and healthy individuals
-
Blignaut E, Messer S, Hollis RJ, Pfaller MA. Antifungal susceptibility of South African oral yeast iso lates from HIV/AIDS patients and healthy individuals. Diagn Microbiol Infect Dis. 2002; 44: 169-174.
-
(2002)
Diagn Microbiol Infect Dis
, vol.44
, pp. 169-174
-
-
Blignaut, E.1
Messer, S.2
Hollis, R.J.3
Pfaller, M.A.4
-
9
-
-
0031920183
-
Comparative evaluation of FUNGITEST and broth mi crodilution methods for antifungal drug susceptibility testing of Candida species and Cryptococcus neoformans
-
Davey KG, Holmes AD, Johnson EM, Szekely A, Warnok DW. Comparative evaluation of FUNGITEST and broth mi crodilution methods for antifungal drug susceptibility testing of Candida species and Cryptococcus neoformans. J Clin Microbiol. 1998; 36: 926-930.
-
(1998)
J Clin Microbiol
, vol.36
, pp. 926-930
-
-
Davey, K.G.1
Holmes, A.D.2
Johnson, E.M.3
Szekely, A.4
Warnok, D.W.5
-
11
-
-
63149184820
-
Early detection of systemic Candidiasis in the whole blood of patients with hematological malignancies
-
Badiee P, Kordbacheh P, Alborzi A, Zakernia M, Haddadi P. Early detection of systemic Candidiasis in the whole blood of patients with hematological malignancies. Jpn Infec Dis. 2009; 62: 1-5.
-
(2009)
Jpn Infec Dis
, vol.62
, pp. 1-5
-
-
Badiee, P.1
Kordbacheh, P.2
Alborzi, A.3
Zakernia, M.4
Haddadi, P.5
-
12
-
-
0032450445
-
Mucosal candidal colo nization and candidiasis in women with or at risk for human immunodeficiency virus infection
-
HIV Epidemiology Research Study (HERS) Group
-
Schuman P, Sobel JD, Ohmit SE, Mayer KH, Carpenter CC, Rompalo A, et al. Mucosal candidal colo nization and candidiasis in women with or at risk for human immunodeficiency virus infection. HIV Epidemiology Research Study (HERS) Group. Clin Infect Dis. 1998; 27: 1161-1167.
-
(1998)
Clin Infect Dis
, vol.27
, pp. 1161-1167
-
-
Schuman, P.1
Sobel, J.D.2
Ohmit, S.E.3
Mayer, K.H.4
Carpenter, C.C.5
Rompalo, A.6
-
13
-
-
13844281731
-
Comparison of standard phenotypic assays with a PCR method to discriminate Candida albicans and Candida dubliniensis
-
Mähnss B, Stehr F, Schäfer WW, Neuber K. Comparison of standard phenotypic assays with a PCR method to discriminate Candida albicans and Candida dubliniensis. Mycoses. 2005; 48: 55-61.
-
(2005)
Mycoses
, vol.48
, pp. 55-61
-
-
Mähnss, B.1
Stehr, F.2
Schäfer, W.W.3
Neuber, K.4
-
14
-
-
0034782669
-
Multicenter prospecti ve surveillance of oral Candida dubliniensis among adult Brazilian human immunodeficiency virus-positive and AIDS patients
-
Milan EP, de Laet Sant' Ana P, de Azevedo Melo AS, Sullivan DJ, Coleman DC, Lewi D, et al. Multicenter prospecti ve surveillance of oral Candida dubliniensis among adult Brazilian human immunodeficiency virus-positive and AIDS patients. Diagn Microbiol Infect Dis. 2001; 41: 29-35.
-
(2001)
Diagn Microbiol Infect Dis
, vol.41
, pp. 29-35
-
-
Milan, E.P.1
de Laet Sant' Ana, P.2
de Azevedo Melo, A.S.3
Sullivan, D.J.4
Coleman, D.C.5
Lewi, D.6
-
15
-
-
33645029908
-
Molecular identification of Candida dubliniensis isolated from oral lesions of HIV-positive and HIV-negative patients in Saõ Paulo, Brazil
-
Chavasco JK, Paula CR, Hirata MH, Aleva NA, Melo CE, Gambale W, et al. Molecular identification of Candida dubliniensis isolated from oral lesions of HIV-positive and HIV-negative patients in Saõ Paulo, Brazil. Rev Inst Med Trop Saõ Paulo. 2006; 48: 21-26.
-
(2006)
Rev Inst Med Trop Saõ Paulo
, vol.48
, pp. 21-26
-
-
Chavasco, J.K.1
Paula, C.R.2
Hirata, M.H.3
Aleva, N.A.4
Melo, C.E.5
Gambale, W.6
-
16
-
-
0035863545
-
The evolution of Candida species and fluconazole susceptibility among oral and vaginal is olates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIVseronegative women
-
Sobel JD, Ohmit SE, Schuman P, Klein RS, Mayer K, Duerr A, et al. The evolution of Candida species and fluconazole susceptibility among oral and vaginal is olates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIVseronegative women. J Infec Dis. 2001; 183: 286-293.
-
(2001)
J Infec Dis
, vol.183
, pp. 286-293
-
-
Sobel, J.D.1
Ohmit, S.E.2
Schuman, P.3
Klein, R.S.4
Mayer, K.5
Duerr, A.6
-
17
-
-
50049102763
-
Species distribution and in vitro antifungal susceptibility of oral yeast isolates from T anzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis
-
Hamza OJ, Matee MI, Moshi MJ, Simon EN, Mugusi F, Mikx FH, et al. Species distribution and in vitro antifungal susceptibility of oral yeast isolates from T anzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis. BMC Microbiol. 2008; 8:135.
-
(2008)
BMC Microbiol
, vol.8
, pp. 135
-
-
Hamza, O.J.1
Matee, M.I.2
Moshi, M.J.3
Simon, E.N.4
Mugusi, F.5
Mikx, F.H.6
-
18
-
-
0032512070
-
Treatment of fluconazole-resistant candidiasis with voriconazole in patients with AIDS
-
Hegener P, Troke PF, Fatkenheuer G, Diehl V, Ruhnke M. Treatment of fluconazole-resistant candidiasis with voriconazole in patients with AIDS. AIDS. 1998; 12: 2227-2228.
-
(1998)
AIDS
, vol.12
, pp. 2227-2228
-
-
Hegener, P.1
Troke, P.F.2
Fatkenheuer, G.3
Diehl, V.4
Ruhnke, M.5
-
19
-
-
0035117864
-
In vitro susceptibility of 137 Candida sp. isolates from HIV positive patients to several antifungal drugs
-
Magaldi S, Mata S, Hartung C, Verde G, Deibis L, Roldán Y, et al. In vitro susceptibility of 137 Candida sp. isolates from HIV positive patients to several antifungal drugs. Mycopathologia. 2001; 149: 63-68.
-
(2001)
Mycopathologia
, vol.149
, pp. 63-68
-
-
Magaldi, S.1
Mata, S.2
Hartung, C.3
Verde, G.4
Deibis, L.5
Roldán, Y.6
-
20
-
-
0033898261
-
Azole cross-resistance to ketoconazole, fluconazole, itraconazole, and voriconazole in clinical Candida albicans isolates from HIV-infected children with oropharyngeal candidosis
-
Müller FM, Weig M, Peter J, Walsh TJ. Azole cross-resistance to ketoconazole, fluconazole, itraconazole, and voriconazole in clinical Candida albicans isolates from HIV-infected children with oropharyngeal candidosis. J Antimicrob Chemother. 2000; 46: 338-340.
-
(2000)
J Antimicrob Chemother
, vol.46
, pp. 338-340
-
-
Müller, F.M.1
Weig, M.2
Peter, J.3
Walsh, T.J.4
-
21
-
-
0036532509
-
The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer
-
Bodey GP, Mardani M, Hanna HA, Baktour M, Abbas J, Girgawy E, et al. The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer. Am J Med. 2002; 112: 380-385.
-
(2002)
Am J Med
, vol.112
, pp. 380-385
-
-
Bodey, G.P.1
Mardani, M.2
Hanna, H.A.3
Baktour, M.4
Abbas, J.5
Girgawy, E.6
-
22
-
-
33847216243
-
Species distribution and antifungal susceptibility of Candida bloodstream isolates in Kuwait: A 10-year study
-
Mokaddas EM, Al-Sweih NA, Khan ZU. Species distribution and antifungal susceptibility of Candida bloodstream isolates in Kuwait: a 10-year study. J Med Microb. 2007; 56: 255-259.
-
(2007)
J Med Microb
, vol.56
, pp. 255-259
-
-
Mokaddas, E.M.1
Al-Sweih, N.A.2
Khan, Z.U.3
-
23
-
-
2442670343
-
Second-line therapy with caspofungin for mucosal or invasive candidiasis: Resul ts from the caspofungin compassionate-use study
-
Kartsonis NA, Saah A, Lipka CJ, Taylor A, Sable CA. Second-line therapy with caspofungin for mucosal or invasive candidiasis: resul ts from the caspofungin compassionate-use study. J Antimicrob Chemother. 2004; 53: 878-881.
-
(2004)
J Antimicrob Chemother
, vol.53
, pp. 878-881
-
-
Kartsonis, N.A.1
Saah, A.2
Lipka, C.J.3
Taylor, A.4
Sable, C.A.5
-
24
-
-
0033807041
-
Refractory mucosal candidiasis in advanced human immunodeficiency virus infection
-
Fichtenbaum CJ, Koletar S, Yiannoutsos C, Holland F, Pottage J, Cohn SE, et al. Refractory mucosal candidiasis in advanced human immunodeficiency virus infection. Clin Infect Dis. 2000; 30: 749-756.
-
(2000)
Clin Infect Dis
, vol.30
, pp. 749-756
-
-
Fichtenbaum, C.J.1
Koletar, S.2
Yiannoutsos, C.3
Holland, F.4
Pottage, J.5
Cohn, S.E.6
|